Safety and Efficacy Evaluation of Serplulimab Plus Chemo in SCLC Transformed From EGFR-mutated NSCLC After Treatment
Clinical trial NCT05957510 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05957510
- Sponsor
- Guangdong Association of Clinical Trials
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-07
- Primary completion
- 2026-07-02
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.